Relapse prevention with second generation tyrosine kinase inhibitors for Ph+ve acute leukemia after allogenic stem cell transplantation. This is an ASCO Meeting Abstract from the 2018 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results